X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Boost Trading
Profits in Four
Easy Steps
DOWNLOAD NOW!
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA Share Price   (AUBD)

Here is the latest stock price and chart of Aurobindo Pharma. For more details, see the Aurobindo Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

REFRESH
Live BSE Quotes Feb 23, 2017 (Close)
Price (Rs)667.15 Open (Rs) 678.00 High (Rs) 680.55 Low (Rs) 663.40
% Change-1.58 Volume 149,454 Value (Rs) 100,631,491 52-Week H/L 895.00 / 582.00
Live NSE Quotes Feb 23, 2017 (Close)
Price (Rs)666.25 Open (Rs) 678.00 High (Rs) 680.90 Low (Rs) 663.00
% Change-1.76 Volume 4,259,200 Value (Rs) 2,855,858,866 52-Week H/L 895.00 / 582.00
Valuation
EPS (Rs)* 39.65 P/E Ratio (x) 16.82 Market Cap (Rs m) 390,395.50 P/BV (x) 5.53
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Aurobindo Pharma Share Price Chart (Rs) - 1 Year
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new


Today's Market

Global Markets Ended on a Mixed Note(RoundUp)

Global stock markets ended the week on a mixed note. Stock markets in Germany and China were the biggest gainers, with gains of 1.7% and 1.6% respectively. Further, Indian stock markets were also up by 1.5%. However, the UK and Brazil share markets were marginally down by 0.6% and 0.5%, respectively.

Related Views On News

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

Glenmark: High Costs hit the Bottom line (Quarterly Results Update - Detailed)

Nov 8, 2016

Glenmark has announced its 2QFY16 results. The company has reported 15.7% YoY growth in net sales and 3.5% YoY increase in net profits. Here is our analysis of the results.

Biocon: High Other Income And Licensing Income Drive Growth (Quarterly Results Update - Detailed)

Nov 7, 2016

Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.

Biocon: Lower R&D Expenses Help Margin Expansion (Quarterly Results Update - Detailed)

Sep 19, 2016

Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.

More Views on News

Most Popular

18.24% Gains in 19 Days... And I Am Still Disappointed(Daily Profit Hunter)

Feb 14, 2017

Apurva closed a trade with gains of 18.24% for his Swing Trader subscribers. But he's not happy about it. Find out why.

Think Twice Before 'Buying' the Buyback(The 5 Minute Wrapup)

Feb 21, 2017

Why buybacks may not always be a tempting proposition.

India's Ecommerce Ponzi Scheme Has Started to Unravel(Vivek Kaul's Diary)

Feb 15, 2017

The investors are writing down their investments in these firms.

TCS Has Maintained a High Payout(Chart Of The Day)

Feb 21, 2017

Will the proposed buyback change the fortunes of TCS?

Don't Believe These Lies About Creating Wealth(Outside View)

Feb 21, 2017

If you think investing in the stock markets can make you wealthy, you need to know this truth.

More

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 5-YR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

MARKET STATS